Study at a glance
What was studied?
Researchers examined human immune cells in the laboratory, including cells from inflamed rheumatoid joints. They measured cell division, inflammatory signals and functions that reduce activation of other cells. Blood-marker reports from one human trial provided a separate comparison.
What was found?
Vitamin D effects differed with time and cell type. One study found greater expansion than in similar cultures not given active hormone at day four but lower division measures than that comparison at day seven. Other experiments found changes in restraining functions. The hormone had less effect on some cells from inflamed joints than on blood-derived cells. Not every inflammatory signal fell.
What does it mean?
Cell expansion, inflammatory signals and tissue recovery are different outcomes. A lower blood marker at one visit and an uncertain difference later do not prove that inflammation resolved or that the true effects differed between visits.
What are the limits?
Cell studies used small samples and often added calcitriol, the active vitamin D hormone, directly. Several shared investigators. They did not show that vitamin D3 supplements prevent harmful immune overactivation or reliably resolve inflammation in people. Research concentrations are not personal doses.
Read the full article below ↓Vitamin D can change the size and timing of immune responses. In one laboratory study, measured expansion was greater than in similar cultures not given active hormone at day four, but relevant division measures were lower than the comparison at day seven. Other experiments found changes in restraining functions. The studies did not establish that supplements prevent harmful overactivation or resolve inflammation in people. The detailed counterpart is Vitamin D and the Timing of Immune Activation and Restraint: Full Evidence Review.
What was studied?
The review examined human cells in the laboratory. T cells help direct immune responses; they were tested after receiving signals to respond. Other experiments measured proteins that can reduce activation of other cells, and cells from inflamed rheumatoid joints. A separate blood-cell study tested whether different immune-cell types responded in the same direction. Human blood-marker results provided a limited comparison with supplementation. These experiments and trial analyses measured different outcomes. [1] [5] [2] [3] [4] [6]
The researchers often added calcitriol, the active hormone, directly to cells. This differs from taking vitamin D3 by mouth. The laboratory concentrations cannot be converted into supplement instructions. Some studies shared investigators; multiple assays do not become independent confirmations.
Did inflammatory signals fall?
In the Chauss experiments, a vitamin-D-dependent programme changed the signals released by activated helper T cells. They produced less interferon-gamma, an inflammatory signal, and more interleukin-10, which can help restrain responses. Interleukin-6 also increased and contributed in that setting. The cells did not simply become a usual type of cell that restrains immune responses. [1]
This is why Vitamin D and Cytokine Balance cannot be reduced to calling each signal good or bad in every situation. A change in one programme does not mean every immune activity fell. The study’s COVID-19 datasets were observational and did not test vitamin D treatment.
Why did timing matter?
Vera and colleagues compared active-hormone-exposed cells with similar comparison cells not given active hormone. Measured division and expansion were greater with hormone at day four, whereas relevant measures were lower than the comparison at day seven. These comparisons at each time do not prove a rise and fall in a person’s cell population. A single time point could therefore give an incomplete answer. Tests involving glutamine, a nutrient cells can use, supported a metabolic contribution. They did not prove a complete mechanism or clinical protection. Samples were small and the analysis of possible mechanisms was preliminary. [5]
Cell expansion, inflammatory signals and tissue recovery are different outcomes. A change in a cell culture does not establish that inflammation resolved in a person.
Could vitamin D preserve a restraining function?
Jeffery’s 2015 experiments tested CTLA-4, a protein that can reduce signals activating other T cells. Calcitriol preserved some measured regulatory functions during inflammatory stimulation. The study tested effects on activating signals and other cells, rather than relying only on a marker. The full checkpoint study is explained in Vitamin D, CTLA-4 and Immune Restraint: Full Study. It did not establish permanent tolerance or disease prevention. [2]
Some cells from inflamed rheumatoid joints were less sensitive to calcitriol than blood-derived cells. The pattern depended on the signal and cell state. It did not show that all memory cells were resistant or establish whether oral supplementation treated rheumatoid arthritis. [3]
Kundu’s study also found increased responses in one kind of blood immune cell and reduced responses in another. This limits any universal claim of immune suppression. Its small uncontrolled human component did not establish a clinical benefit. [4]
What remains uncertain?
The VITAL blood-marker reports came from one parent trial. The later report found lower high-sensitivity C-reactive protein, a blood inflammatory marker, at year two but did not establish a clear difference at year four. Other measured blood markers did not show a consistent reduction. This does not itself establish that the true effects differed between visits. Blood markers still do not directly establish tissue recovery. [6] [7]
Vitamin D and Systemic Regulation concerns whole-body regulation. From Cellular Cytokine Responses to Systemic Inflammation explains why cellular and systemic measurements should stay separate. Vitamin D and Immune Overactivation concerns harmful overactivation, but the studies here do not prove its prevention in people.
The effects depended on the cell, vitamin D form, existing inflammation and measurement time. These studies did not establish that supplements prevent harmful immune overactivation or resolve inflammation in people.
Primary sources
[1] Chauss D et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3. PMID: 34764490.
[2] Jeffery LE et al. Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function. PloS one. 2015;10(7):e0131539. DOI: 10.1371/journal.pone.0131539. PMID: 26134669.
[3] Jeffery LE et al. Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint. Journal of autoimmunity. 2018;88:50-60. DOI: 10.1016/j.jaut.2017.10.001. PMID: 29066221.
[4] Kundu R et al. Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Immunology. 2017;150(1):55-63. DOI: 10.1111/imm.12669. PMID: 27608289.
[5] Vera AA et al. Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis. Frontiers in immunology. 2026;17:1791098. DOI: 10.3389/fimmu.2026.1791098. PMID: 42367775.
[6] Dong Y et al. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Nutrients. 2022;14(24):5307. DOI: 10.3390/nu14245307. PMID: 36558465.
[7] Costenbader KH et al. Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. Clinical chemistry. 2019;65(12):1508-1521. DOI: 10.1373/clinchem.2019.306902. PMID: 31699704.
Related reading
Metabolic and behavioral features of acute hyperpurinergia and the maternal immune activation mouse model of autism spectrum disorder
Since 2012, studies in mice, rats, and humans have suggested that abnormalities in purinergic signaling may be a final common pathway for many genetic and environmental causes of autism spectrum disorder (ASD).
Original paper ↗Read more →Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes
Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism.
Original paper ↗Read more →Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
1,25(OH)2D3 had significantly less suppressive effect on Th17 cells (IL-17+IFNγ-) and Th17.1 cells (IL-17+IFNγ+) from SF compared to those from blood, and had no effect on SF CD4+ or CD8+ IFNγ+ T cell frequencies.
Original paper ↗Read more →Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Original paper ↗Read more →Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines on CTLA-4 Expression and Regulatory Function
Therefore, in this study we have examined the effects of Th17 polarising conditions on CTLA-4 expression and function in human T cells and show that Th17 conditions can suppress the expression of CTLA-4 and its transendocytic function.
Original paper ↗Read more →Germanane Quantum Dots Promote Metabolic Reprogramming of Immune Cells Toward Regulatory T Cells and Suppress Inflammation In Vitro and In Vivo
Recently, nanomaterials have emerged as a tool in developing novel therapies against inflammatory diseases.
Original paper ↗Read more →Calcitriol Reduces the Inflammation, Endothelial Damage and Oxidative Stress in AKI Caused by Cisplatin
Cisplatin treatment is one of the most commonly used treatments for patients with cancer.
Original paper ↗Read more →Effect of calcitriol supplementation on infectious biomarkers in patients with positive systemic inflammatory response: A Randomized Controlled Trial
The serum levels of procalcitonin and presepsin were evaluated on days 0, 3, and 5 after administration.
Original paper ↗Read more →Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice
Culture supernatants were collected every 24 h post infection and the viral growth kinetics and inflammatory response were evaluated.
Original paper ↗Read more →Modulation of renal inflammation and tubular injury by calcitriol in patients with early diabetic kidney disease: a randomized controlled trial
This double-blind, randomized controlled trial investigated the effects of calcitriol supplementation on kidney injury biomarkers in patients with early DKD.
Original paper ↗Read more →Anti-Inflammatory Effects of Vitamin D on Human Immune Cells in the Context of Bacterial Infection
Vitamin D induces a diverse range of biological effects, including important functions in bone health, calcium homeostasis and, more recently, on immune function.
Original paper ↗Read more →In Vivo Regulation of Signal Transduction Pathways by Vitamin D Stabilizes Homeostasis of Human Immune Cells and Counteracts Molecular Stress
Eight of the pathways show an approximately even contribution of up: and downregulated genes, suggesting that the actions of vitamin D stabilize homeostasis of the physiological processes driven by the respective signaling cascades.
Original paper ↗Read more →Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
In this study, we investigated the therapeutic effects of vitamin D receptor activation by calcitriol on PD, specifically focusing on its role in Treg.
Original paper ↗Read more →Vitamin D and the Timing of Immune Activation and Restraint: Full Evidence Review
How vitamin D can alter immune activation, restraint and timing, with cell-type differences and the limits of claims about inflammation resolution.
Read more →Vitamin D, CTLA-4 and Immune Restraint: Full Study
Human T-cell experiments link active vitamin D to CTLA-4-mediated immune restraint.
Read more →Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes
We found that calcitriol-treated HL-1 cells had significantly reduced FGFR1 expression compared to control cells.
Original paper ↗Read more →Cord Serum Calcitriol Inversely Correlates with Maternal Blood Pressure in Urinary Tract Infection-Affected Pregnancies: Sex-Dependent Immune Implications
UTI-female placentas showed higher expression of cathelicidin and CYP27B1, the calcitriol activating-enzyme, compared to male and NP samples.
Original paper ↗Read more →High systemic immune‐inflammation index is relevant to osteoporosis among middle‐aged and older people: A cross‐sectional study
As one of novel inflammatory indexes proposed in recent years, systemic immune‐inflammation index (SII) can comprehensively reflect the inflammatory and immune state of the body.
Original paper ↗Read more →The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia
To this end, we investigated whether the calcitriol/VDR system is functional in CLL and analyzed key signaling pathways that are regulated by calcitriol supplementation, while also exploring the role of microenvironmental signals in the regulation of calcitriol/VDR system.
Original paper ↗Read more →Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Study Summary
A concise guide to endothelial inflammation and vitamin D: what cell experiments measure, where their findings differ, and why clinical benefit remains uncertain.
Read more →Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study
In an exploratory analysis, we compared the clinical outcomes of cohort 1 with a control cohort of patients followed at the participating centers who did not receive systematic vitamin D repletion.
Original paper ↗Read more →Original sources
Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
Published in Nature immunology (2022).
Publication details
[1] Chauss D et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nature immunology. 2022;23(1):62-74. DOI: 10.1038/s41590-021-01080-3. PMID: 34764490.
Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint
1,25(OH)2D3 had significantly less suppressive effect on Th17 cells (IL-17+IFNγ-) and Th17.1 cells (IL-17+IFNγ+) from SF compared to those from blood, and had no effect on SF CD4+ or CD8+ IFNγ+ T cell frequencies.
Publication details
[3] Jeffery LE et al. Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint. Journal of autoimmunity. 2018;88:50-60. DOI: 10.1016/j.jaut.2017.10.001. PMID: 29066221.
Cell‐type‐specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes
Vitamin D is widely reported to inhibit innate immune signalling and dendritic cell (DC) maturation as a potential immunoregulatory mechanism.
Publication details
[4] Kundu R et al. Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Immunology. 2017;150(1):55-63. DOI: 10.1111/imm.12669. PMID: 27608289.
Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis
Published in Frontiers in immunology (2026).
Publication details
[5] Vera AA et al. Vitamin D supports activated CD4+ T-cell proliferation through enhanced glutaminolysis. Frontiers in immunology. 2026;17:1791098. DOI: 10.3389/fimmu.2026.1791098. PMID: 42367775.
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Published in Nutrients (2022).
Publication details
[6] Dong Y et al. Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Nutrients. 2022;14(24):5307. DOI: 10.3390/nu14245307. PMID: 36558465.
Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults
Published in Clinical chemistry (2019).
Publication details
[7] Costenbader KH et al. Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. Clinical chemistry. 2019;65(12):1508-1521. DOI: 10.1373/clinchem.2019.306902. PMID: 31699704.